Phenytoin-induced hyperglycaemia may confound rat cerebroprotection models

Clinical and Experimental Pharmacology and Physiology

Volumn 23, Issue 10-11, 1996, Pages 893-897

  Qi, Hui ^b   Newman, George C ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b NONE

Author keywords

Fos phenytoin; Hyperglycaemia; Hypothermia; Ischaemia; Phenytoin

Indexed keywords

PHENYTOIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; BRAIN PROTECTION; DRUG BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HYPERGLYCEMIA; HYPOTHERMIA; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; RAT;

EID: 0029826344     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1996.tb01140.x     Document Type: Article

References (34)

1. Cullen JP, Aldrete JA, Jankovsky L, Romo-Salas F. Protective action of phenytoin in cerebral ischemia. Anesth. Analg. 1979; 58: 165-9.
2. Suzuki J, Abiko H, Mizoi K, Oba M, Yoshimoto T. Protective effect of phenytoin and its enhanced action by combined administration with mannitol and vitamin E in cerebral ischaemia. Acta Neurochir. 1987; 88: 56-64.
3. Taft WC, Clifton GL, Blair RE, DeLorenzo RJ. Phenytoin protects against ischemia-produced neuronal cell death. Brain Res. 1989; 483: 143-8.
4. Kinouchi H, Imaizumi S, Yoshimoto T, Motomiya M. Phenytoin affects metabolism of free fatty acids and nucleotides in rat cerebral ischaemia. Stroke 1990; 21: 1326-32.
5. Seymour RL, Booker J Jr, Desmond FS, Gerold MG. Inhibition of insultin secretion by diphenylhydantoin in the isolated perfused pancreas. J. Clin. Endocrinol. 1970; 30: 400-1.
6. Malherbe C, Burrill KC, Levin SR. Effect of diphenylhydantoin on insulin secretion in man. N. Engl. J. Med. 1972; 286: 339-42.
7. Pace CS, Livingston E. Ionic basis of phenytoin sodium inhibition of insulin secretion in pancreatic islets. Diabetes 1979; 28: 1077-82.
8. Newman GC, Hospod FE, Patlak CS, Hui Q. Radiotracer labelling of brain slices. In: Schurr A (ed.). Brain Slices Methods. CRC Press, Boca Raton. 1995; 1987-220.
9. Peters BH, Samaan NA. Hyperglycemia with relative hypoinsulinemia in diphenylhydantoin toxicity. N. Engl. J. Med. 1969; 281: 91-2.
10. Al-Rubeaan K, Ryan EA. Phenytoin-induced insulin insensitivity. Diabetic Med. 1991; 8: 968-70.
11. Boucher BA, Bombassaro AM, Rasmussen SN, Watridge CB, Achari R, Turlapaty P. Phenytoin prodrug 3-phosphoryloxymethyl phenytoin (ACC-9653): Pharmacokinetics in patients following intravenous and intramuscular administration. J. Pharm. Sci. 1989; 78: 929-32.
12. Famerson BD, Donn KH, Dules GE, Messenheimer JA, Brouwer KL, Robert Powell, J. Absolute bioavailability of phenytoin after 3-phosphoryloxymethyl phenytoin disodium (ACC-9653) administration to humans. Epilepsia 1990; 31: 592-7.
13. Smith RD, Brown BS, Maher RW, Matier WL. Pharmacology of ACC-9653 (phenytoin prodrug). Epilepsia 1989; 30 (Suppl. 2): S15-21.
14. Fariss BL, Lutcher CL. Diphenylhydantoin-induced hyperglycemia and impaired insulin release, effect of dosage. Diabetes 1971; 29: 177-81.
15. Kizer JS, Vargas-Cordon M, Brendel K, Bressler E. The in vitro inhibition of insulin secretion by diphenylhydantoin. J. Clin. Invest. 1970; 49: 1942-7.
16. Levin SR, Grodsky GM, Hagura R, Smith D. Comparison of the inhibitory effects of diphenylhydantoin and diazoxide upon insulin secretion from the isolated perfused pancreas. Diabetes 1972; 21: 856-62.
17. Meissner HP, Schmelz H. Membrane potential of beta cells in pancreatic islets. Pflügers Arch. 1974; 351: 195-206.
18. Meissner HP. Electrical characteristics of the beta-cells in pancreatic islets. J. Physiol. 1976; 72: 757-67.
19. Matthews EK, Sakamoto Y. Pancreatic islet cells: Electrogenic and electrodiffusional control of membrane potential. J. Physiol. 1975; 246: 439-57.
20. Naber SP, McDaniel M, Lacy PE. The effect of glucose on the acute uptake and efflux of calcium-45 in isolated rat islets. Endocrinology 1977; 101: 686-93.
21. ++ efflux from isolated islets. Endocrinology 1978; 102: 1339-49.
22. Wollheim CB, Sharp GWG. The regulation of insulin release by calcium. Physiol. Rev. 1981; 61: 914-73.
23. ++ fluxes in rat pancreatic islets. Diabetes 1982; 31: 265-9.
24. Rehncrona S, Rosen I, Siesjo BK. Brain lactic acidosis and ischemic cell damage: 1. Biochemistry and neurophysiology. J. Cereb. Blood Flow Metab. 1981; 1: 297-311.
25. Riddle MC, Hart J. Hyperglycemia, recognized and unrecognized, as a risk factor for stroke and transient ischemic attacks. Stroke 1982; 13: 356-9.
26. Pulsinelli WA, Levy DE, Sigsbee B, Scherer P, Plum F. Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus. Am. J. Med. 1988; 74: 540-4.
27. Cox NH, Lorains JW. The prognostic value of blood glucose and glycosylated haemoglobin estimation in patients with stroke. Postgrad. Med. J. 1986; 62: 7-10.
28. Siemkowicz E, Hansen AJ. Brain extracellular ion composition and EEG activity following 10 minutes ischemia in normo- and hyperglycemic rats. Stroke 1981; 2: 236-40.
29. Rehncrona S, Rosen I, Smith MJ. Effect of different degrees of brain ischemia and tissue lactic acidosis on the short-term recovery of neurophysiologic and metabolic variables. Exp. Neurol. 1985; 87: 458-73.
30. Marsh R, Anderson RE, Sundt TM. Effect of hyperglycemia on brain pH levels in areas of local incomplete cerebral ischemia in monkeys. J. Neurosurg. 1986; 65: 693-6.
31. Smith ML, von Hanwehr R, Siesjo BK. Changes in extra- and intracellular pH in the brain during and following ischemia in hyperglycemic and in moderately hyperglycemic rats. J. Cereb. Blood Flow Metab. 1986; 6: 574-83.
32. Siesjo BK. Acidosis and ischemic brain damage. Neurochem. Pathol. 1988; 9: 31-88.
33. Siesjo BK, Ekholm A, Katsura K. Acid-base change during complete brain ischemia. Stroke 1990; 21 (Suppl. III): 194-9.
34. Warner DS, Gionet TX, Todd MM, Mcallister AM. Insulin-induced normoglycemia improves ischemic outcome in hyperglycemic rats. Stroke 1992; 23: 1775-81.